SPE2D2-22-D-0145 Estradiol Patch 24 Contract SPE2D221R0115
Summary
AI-generated · Aug 24, 2025Supply of Estradiol 24-hour transdermal patches under SPE2D222D0145 includes amendments to add DCSA security language to the solicitation, invoke Option Year 1, incorporate FAR 52.204-27 prohibiting ByteDance-covered applications, and adjust the delivery start date.
Awarded to Mylan Pharmaceuticals Inc. for $9,549,893.15.
2025-08-20 Modifications P00005 through P00008 added Modification P00004 SPE2D222D0145 to incorporate DCSA language into soliciation for subject contract. Modification P00003 SPE2D222D0145 to Invoke Option Year 1 for the period August 26, 2023 to August 25, 2024. Modification P00002 SPE2D222D0145 to incorporate FAR 52.204-27 Prohibition on a Byetdance Covered Application (June 2023) into contract. Modification P00001 SPE2D222D0145 to change delivery start date. Contract Award for Estradiol 24HR Patches SPE2D222D0145
From Award Notice posted on Aug 20, 2025Notice history
1Details
Award Information
Award Notices
Posted: Aug 20, 2025
2025-08-20 Modifications P00005 through P00008 added Modification P00004 SPE2D222D0145 to incorporate DCSA language into soliciation for subject contract. Modification P00003 SPE2D222D0145 to Invoke Option Year 1 for the period August 26, 2023 to August 25, 2024. Modification P00002 SPE2D222D0145 to...
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | NDN1MYB8DKK5 | 3KJG9 | Morgantown, WV |
Documents
9Contacts
Phone
Agency
Place of Performance
USA